Adicet Bio, Inc. — Director's Dealing 2026

Jan 27, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2026-01-24

Reporting Person: Schor Chen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-24	Common Stock	F	1755	$8.44	Disposed	6820	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2716	Indirect
Common Stock	3339	Indirect

Footnotes

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

F2: Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025.

F3: Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

F4: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.